Abstract Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Cardiac magnetic resonance (CMR) has become an essential tool for the evaluation of
patients affected or at risk of developing cardiomyopathies (CMPs). In fact, CMR not only …

ABSTRACT Aim The “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure”
replaces the “2013 ACCF/AHA Guideline for the Management of Heart Failure” and the …

Objectives The aim of this study is to examine the prognostic value of T1 mapping and the
extracellular volume (ECV) fraction in patients with dilated cardiomyopathy (DCM) …

Objectives This study sought to evaluate the effects of empagliflozin on extracellular volume
(ECV) in individuals with type 2 diabetes mellitus (T2DM) and coronary artery disease …

Myocardial fibrosis, seen in ischemic and nonischemic cardiomyopathies, is associated with
adverse cardiac outcomes. Noninvasive imaging plays a key role in early identification and …

Risk stratification based mainly on the impairment of left ventricular ejection fraction has
limited performance in patients with nonischemic dilated cardiomyopathy (NIDCM) …

Background: The prognosis of patients with idiopathic dilated cardiomyopathy (DCM) has
improved remarkably in recent decades with guideline-directed medical therapy. Left …

Objectives Because risk stratification data represents a key domain of biomarker validation,
we compared associations between outcomes and various cardiovascular magnetic …

Objective To investigate the prognostic significance of T1 mapping using T1 long and short
in hypertrophic cardiomyopathy (HCM) patients. Methods A total of 263 consecutive patients …